Russia is creating a personalized mRNA cancer vaccine and intends to begin treating patients in October 2025.
The vaccine, EnteroMix, was developed using technology similar to that of the COVID-19 mRNA vaccines.
“The vaccine uses AI-driven algorithms to create individualized mRNA blueprints based on patient genetic data, reducing development time
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!